Maternal immune activation during pregnancy impacts on brain structure and function in the adult offspring.


Journal

Brain, behavior, and immunity
ISSN: 1090-2139
Titre abrégé: Brain Behav Immun
Pays: Netherlands
ID NLM: 8800478

Informations de publication

Date de publication:
01 2020
Historique:
received: 18 02 2019
revised: 03 09 2019
accepted: 12 09 2019
pubmed: 19 9 2019
medline: 9 3 2021
entrez: 19 9 2019
Statut: ppublish

Résumé

Gestational infection constitutes a risk factor for the occurrence of psychiatric disorders in the offspring. Activation of the maternal immune system (MIA) with subsequent impact on the development of the fetal brain is considered to form the neurobiological basis for aberrant neural wiring and the psychiatric manifestations later in offspring life. The examination of validated animal models constitutes a premier resource for the investigation of the neural underpinnings. Here we used a mouse model of MIA based upon systemic treatment of pregnant mice with Poly(I:C) (polyriboinosinic-polyribocytidilic acid), for the unbiased and comprehensive analysis of the impact of MIA on adult offspring brain activity, morphometry, connectivity and function by a magnetic resonance imaging (MRI) approach. Overall lower neural activity, smaller brain regions and less effective fiber structure were observed for Poly(I:C) offspring compared to the control group. The corpus callosum was significantly smaller and presented with a disruption in myelin/ fiber structure in the MIA progeny. Subsequent resting-state functional MRI experiments demonstrated a paralleling dysfunctional interhemispheric connectivity. Additionally, while the overall flow of information was intact, cortico-limbic connectivity was hampered and limbic circuits revealed hyperconnectivity in Poly(I:C) offspring. Our study sheds new light on the impact of maternal infection during pregnancy on the offspring brain and identifies aberrant resting-state functional connectivity patterns as possible correlates of the behavioral phenotype with relevance for psychiatric disorders.

Identifiants

pubmed: 31526827
pii: S0889-1591(19)30178-3
doi: 10.1016/j.bbi.2019.09.011
pii:
doi:

Substances chimiques

Poly I-C O84C90HH2L

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

56-67

Subventions

Organisme : Austrian Science Fund FWF
ID : P 27520
Pays : Austria

Informations de copyright

Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Auteurs

Silke Kreitz (S)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany.

Alice Zambon (A)

Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Austria.

Marianne Ronovsky (M)

Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Austria.

Lubos Budinsky (L)

Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria.

Thomas H Helbich (TH)

Department of Biomedical Imaging and Image-Guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Austria.

Spyros Sideromenos (S)

Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Austria.

Claudiu Ivan (C)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany.

Laura Konerth (L)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany.

Isabel Wank (I)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany.

Angelika Berger (A)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.

Arnold Pollak (A)

Department of Pediatrics and Adolescent Medicine, Medical University of Vienna, Austria.

Andreas Hess (A)

Institute of Experimental and Clinical Pharmacology and Toxicology, Friedrich-Alexander University Erlangen-Nürnberg (FAU), Germany. Electronic address: andreas.hess@fau.de.

Daniela D Pollak (DD)

Department of Neurophysiology and Neuropharmacology, Medical University of Vienna, Austria. Electronic address: daniela.pollak@meduniwien.ac.at.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH